← All trials
NCT00775606
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2008
- Primary completion
- Dec 1, 2010
- Completion date
- Jan 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Rush UniversityLead sponsor
- Rush UniversityStudy chair
- University of ChicagoCollaborator
- Ruth M. Rothstein CORE CenterCollaborator
- AbbottCollaborator
- Gilead SciencesCollaborator
- Rush UniversityReponsible party - principal investigator
- University of Illinois at ChicagoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.